These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29326076)

  • 1. Phage-derived lysins as potential agents for eradicating biofilms and persisters.
    Sharma U; Vipra A; Channabasappa S
    Drug Discov Today; 2018 Apr; 23(4):848-856. PubMed ID: 29326076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.
    Vázquez R; García E; García P
    Front Immunol; 2018; 9():2252. PubMed ID: 30459750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysins: the arrival of pathogen-directed anti-infectives.
    Pastagia M; Schuch R; Fischetti VA; Huang DB
    J Med Microbiol; 2013 Oct; 62(Pt 10):1506-1516. PubMed ID: 23813275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages and Lysins in Biofilm Control.
    Łusiak-Szelachowska M; Weber-Dąbrowska B; Górski A
    Virol Sin; 2020 Apr; 35(2):125-133. PubMed ID: 32125643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage endolysins as a novel class of antibacterial agents.
    Borysowski J; Weber-Dabrowska B; Górski A
    Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage lysins as effective antibacterials.
    Fischetti VA
    Curr Opin Microbiol; 2008 Oct; 11(5):393-400. PubMed ID: 18824123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.
    Oliveira H; São-José C; Azeredo J
    Viruses; 2018 May; 10(6):. PubMed ID: 29844287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationship of Amino Acid Tunable Lipidated Norspermidine Conjugates: Disrupting Biofilms with Potent Activity against Bacterial Persisters.
    Konai MM; Adhikary U; Samaddar S; Ghosh C; Haldar J
    Bioconjug Chem; 2015 Dec; 26(12):2442-53. PubMed ID: 26452096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens.
    Fischetti VA
    Curr Top Microbiol Immunol; 2017; 409():529-540. PubMed ID: 26728063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.
    Raz A; Serrano A; Hernandez A; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate.
    Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):848-859. PubMed ID: 28132897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous bacterial persisters and engineering approaches to eliminate them.
    Allison KR; Brynildsen MP; Collins JJ
    Curr Opin Microbiol; 2011 Oct; 14(5):593-8. PubMed ID: 21937262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage and their lysins for elimination of infectious bacteria.
    O'Flaherty S; Ross RP; Coffey A
    FEMS Microbiol Rev; 2009 Jul; 33(4):801-19. PubMed ID: 19416364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
    Nair S; Poonacha N; Desai S; Hiremath D; Tuppad D; Mohan T; Chikkamadaiah R; Durgaiah M; Kumar S; Channabasappa S; Vipra A; Sharma U
    J Med Microbiol; 2018 Mar; 67(3):296-307. PubMed ID: 29458674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of bacteriophages to biocontrol oral biofilms.
    Szafrański SP; Winkel A; Stiesch M
    J Biotechnol; 2017 May; 250():29-44. PubMed ID: 28108235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.
    Hansen MF; Svenningsen SL; Røder HL; Middelboe M; Burmølle M
    Trends Microbiol; 2019 Sep; 27(9):739-752. PubMed ID: 31128928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriophage lysins: progress and perspective--a review].
    Wang Y; Lu C
    Wei Sheng Wu Xue Bao; 2009 Oct; 49(10):1277-81. PubMed ID: 20069871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
    Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
    J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agents that inhibit bacterial biofilm formation.
    Rabin N; Zheng Y; Opoku-Temeng C; Du Y; Bonsu E; Sintim HO
    Future Med Chem; 2015; 7(5):647-71. PubMed ID: 25921403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.